EPWCF has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
EPWCF has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Empower Clinics's Enterprise Value is $4.41 Mil. Empower Clinics's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 was $-4.56 Mil. Therefore, Empower Clinics's EV-to-EBIT for today is -0.97.
The historical rank and industry rank for Empower Clinics's EV-to-EBIT or its related term are showing as below:
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Empower Clinics's Enterprise Value for the quarter that ended in Sep. 2022 was $4.40 Mil. Empower Clinics's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 was $-4.56 Mil. Empower Clinics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 was -103.60%.
The historical data trend for Empower Clinics's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Empower Clinics Annual Data | |||||||||||||||||||||
Trend | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | |||||||||||
EV-to-EBIT | Get a 7-Day Free Trial | -4.07 | -2.07 | -1.80 | -3.74 | -2.72 |
Empower Clinics Quarterly Data | ||||||||||||||||||||
Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | |
EV-to-EBIT | Get a 7-Day Free Trial | -2.56 | -2.72 | -7.12 | -5.03 | -4.01 |
For the Medical Care Facilities subindustry, Empower Clinics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Empower Clinics's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Empower Clinics's EV-to-EBIT falls into.
Empower Clinics's EV-to-EBIT for today is calculated as:
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 4.405 | / | -4.558 | |
= | -0.97 |
Empower Clinics's current Enterprise Value is $4.41 Mil.
Empower Clinics's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Empower Clinics (OTCPK:EPWCF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.
Empower Clinics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 is calculated as:
Earnings Yield (Joel Greenblatt) % (Q: Sep. 2022 ) | = | EBIT | / | Enterprise Value (Q: Sep. 2022 ) |
= | -4.558 | / | 4.399485085 | |
= | -103.60 % |
Empower Clinics's Enterprise Value for the quarter that ended in Sep. 2022 was $4.40 Mil.
Empower Clinics's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Empower Clinics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
John Kenneth Campbell | director | 905 WEST PENDER ST STE 500, VANCOUVER BC CANADA A1 V6C1L6 |
Dan Brown | director | 4615 232ND STREET, LANGLEY A1 V2Z 2S1 |
Michael Barry Hart | officer: Pres/Prin Exe Officer/Sec/Trea | 3331 BEACH AVE, ROBERTS CREEK A1 V0N 2W2 |
Garth Johnson | officer: CFO | 1407 - 1050 BURRARD ST., VANCOUVER A1 V6Z 2S3 |
Trans Orient Petroleum Ltd/ | 10 percent owner | WORLD TRADE CENTRE, SUITE 404-999 CANADA PLACE, VANCOUVER A1 V6C 3E2 |
Robert Pollock | 10 percent owner | 94 GARFIELD AVENUE, TORONTO A6 M4T 1G1 |
Doug Lynes | director | SUITE 350 - 6165 HIGHWAY 17, DELTA A1 V4K 5B8 |
Alex Guidi | 10 percent owner | 1055 WEST GEORGIA STREET, SUITE 1500, VANCOUVER A1 V6E 4N7 |
From GuruFocus
By ACCESSWIRE ACCESSWIRE • 06-06-2023
By ACCESSWIRE • 08-15-2023
By ACCESSWIRE • 07-31-2023
By ACCESSWIRE ACCESSWIRE • 03-21-2023
By ACCESSWIRE ACCESSWIRE • 03-20-2023
By ACCESSWIRE ACCESSWIRE • 05-20-2023
By ACCESSWIRE ACCESSWIRE • 12-24-2022
By ACCESSWIRE ACCESSWIRE • 02-28-2023
By ACCESSWIRE ACCESSWIRE • 01-10-2023
By ACCESSWIRE ACCESSWIRE • 12-07-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.